Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 15.65 Delayed Data As of Jul 21 |  -0.10 / -0.63%Today’s Change | 14.80 Today|||52-Week Range 18.18 | -7.23% Year-to-Date |
| Angiodynamics Inc (ANGO) President and CEO James C Clemmer Bought $391,750 of Shares Jul 21 / GuruFocus News - Paid Partner Content | AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Jul 19 / Zacks.com - Paid Partner Content |
| Previous close | 15.75 |
| Today’s open | 15.89 |
| Day’s range | 15.58 - 15.93 |
| Volume | 325,430 |
| Average volume (3 months) | 271,742 |
| Market cap | $575.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +0.00% |
| P/E ratio | NM |
| Price/Sales | 1.59 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| LMATLeMaitre Vascular In... | -0.89 | -3.05% |
| CRYCryoLife Inc | -0.25 | -1.29% |
| TCMDTactile Systems Tech... | -0.03 | -0.10% |
| GNMKGenMark Diagnostics ... | -0.21 | -1.71% |
| Last reporting date | July 18, 2017 |
| EPS forecast (this quarter) | $0.16 |
| Annual revenue (last year) | $351.5M |
| Annual profit (last year) | $7.0M |
| Net profit margin | 1.99% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director James C. Clemmer |
Senior Vice President- Global Operations Barbara Kucharczyk |
Corporate headquarters Latham, New York |
